HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 0.24
Day range
kr 0.24 - kr 0.26
Year range
kr 0.13 - kr 0.36
Market cap
390.71M SEK
Avg Volume
14.78M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 93.24M | 562.90% |
Operating expense | 25.02M | -69.50% |
Net income | 8.16M | 108.38% |
Net profit margin | 8.76 | 101.26% |
Earnings per share | 0.01 | 103.34% |
EBITDA | 32.83M | 148.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.71M | -90.84% |
Total assets | 696.32M | -22.51% |
Total liabilities | 480.06M | -4.85% |
Total equity | 216.26M | — |
Shares outstanding | 1.53B | — |
Price to book | 1.75 | — |
Return on assets | 9.07% | — |
Return on capital | 18.22% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 8.16M | 108.38% |
Cash from operations | -68.64M | 39.37% |
Cash from investing | -24.02M | -4,693.81% |
Cash from financing | -6.74M | -102.13% |
Net change in cash | -99.62M | -148.75% |
Free cash flow | -115.52M | -55.65% |
About
CEO
Founded
2008
Website
Employees
64
